Questions raised over hydroxychloroquine imported from India, expulsion of scientist in US


New Delhi, May 5, 2020

A scientist with a government job in the United States has accused the government of expelling him for questioning the quality of a hydroxychloroquine drug being imported from India and Pakistan.

Rick Bright, of the Department of Health and Human Resource Development, has also filed a complaint with the U.S. Office of Special Counsel, alleging that his superiors ignored the warnings he had given, and in particular the hydroxychloroquine used to treat corona. Have done.

Bright alleges that drug imports from Pakistan and India are a matter of great concern because the US Federal Drug Authority has not inspected the factory where the drugs are made. The drugs may also be counterfeit and pose a risk to public health. Can also occur.

The United States has ordered 50 million hydroxychloroquine in response to the emergency. Bright alleges I insisted on spending on safe and scientifically certified resources, which led to my removal.

Comments